Julia GraboHealth Policy Client AssistantMcDermott Will & Emery Websitewww.mcdermottplus.comOrganization ProfileFull ProfileBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn202-756-8761 Professional Biography Julia produces comprehensive research and analysis of key federal healthcare policy developments and legislative initiatives. More Legal and Business Bylines From Julia Grabo McDermottPlus Check-Up: May 24, 2024 - (Posted On Friday, May 24, 2024) McDermottPlus Check-Up: May 17, 2024 - (Posted On Friday, May 17, 2024) Exploring the Virtual Care Policy Landscape One Year Post-PHE - (Posted On Thursday, May 16, 2024) McDermottPlus Check-Up: May 10, 2024 - (Posted On Friday, May 10, 2024) McdermottPlus Check-Up: May 3, 2024 - (Posted On Friday, May 03, 2024) Organ Procurement and Transplantation Network: What’s Next in Oversight and Reform - (Posted On Tuesday, January 09, 2024) Current Legal Analysis Breaking Down Federal Policies to Address Drug Shortages by: McDermott + Consulting PPPlease Stop Fraud: Two Whistleblowers Awarded $2.5 Million in PPP Fraud Settlement by: Tycko & Zavareei Whistleblower Practice Group On July 1, 2024, Texas May Have the Strongest Consumer Data Privacy Law in the United States by: Elizabeth Rogers 10 Creative Ways for Lawyers to Repurpose Content by: Stefanie M. Marrone FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company by: Dominick DiSabatino , Cortney Inman Upcoming Legal Education Events Jun 26 2024 TSCA Reform — Eight Years Later Jun 18 2024 There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e) Jun 12 2024 Preparing for HHS’s 340B Administrative Dispute Resolution (“ADR”) Reboot – Lessons from the Field Jun 12 2024 Sponsor’s Role in Regulatory Testing — Complying with GLP Standards Print